• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用蛋白质组学分析方法来描述不同胸腺瘤亚型的蛋白质特征。

Using proteomic profiling to characterize protein signatures of different thymoma subtypes.

机构信息

Graduate Institute of Physiology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan.

Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, 10055, Taiwan.

出版信息

BMC Cancer. 2019 Aug 13;19(1):796. doi: 10.1186/s12885-019-6023-4.

DOI:10.1186/s12885-019-6023-4
PMID:31409307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6693091/
Abstract

BACKGROUND

Histology is a traditional way to classify subtypes of thymoma, because of low cost and convenience. Yet, due to the diverse morphology of thymoma, this method increases the complexity of histopathologic classification, and requires experienced experts to perform correct diagnosis. Therefore, in this study, we developed an alternative method by identifying protein biomarkers in order to assist clinical practitioners to make right classification of thymoma subtypes.

METHODS

In total, 204 differentially expressed proteins in three subtypes of thymoma, AB, B2, and B3, were identified using mass spectrometry. Pathway analysis showed that the differentially expressed proteins in the three subtypes were involved in activation-related, signaling transduction-related and complement system-related pathways. To predict the subtypes of thymoma using the identified protein signatures, a support vector machine algorithm was used. Leave-one-out cross validation methods and receiver operating characteristic analysis were used to evaluate the predictive performance.

RESULTS

The mean accuracy rates were > 80% and areas under the curve were ≧0.93 across these three subtypes. Especially, subtype B3 had the highest accuracy rate (96%) and subtype AB had the greatest area under the curve (0.99). One of the differentially expressed proteins COL17A2 was further validated using immunohistochemistry.

CONCLUSIONS

In summary, we identified specific protein signatures for accurately classifying subtypes of thymoma, which could facilitate accurate diagnosis of thymoma patients.

摘要

背景

组织学是一种传统的胸腺瘤亚型分类方法,因为成本低且方便。然而,由于胸腺瘤形态多样,这种方法增加了组织病理学分类的复杂性,需要有经验的专家进行正确的诊断。因此,在这项研究中,我们通过鉴定蛋白质生物标志物开发了一种替代方法,以帮助临床医生正确分类胸腺瘤亚型。

方法

使用质谱法共鉴定出三种胸腺瘤亚型(AB、B2 和 B3)中的 204 个差异表达蛋白。通路分析显示,三种亚型中的差异表达蛋白参与了激活相关、信号转导相关和补体系统相关通路。为了使用鉴定的蛋白特征预测胸腺瘤的亚型,使用了支持向量机算法。采用留一法交叉验证方法和受试者工作特征分析来评估预测性能。

结果

这三种亚型的平均准确率均>80%,曲线下面积均≧0.93。特别是,B3 亚型的准确率最高(96%),AB 亚型的曲线下面积最大(0.99)。进一步使用免疫组织化学法验证了其中一个差异表达蛋白 COL17A2。

结论

总之,我们鉴定了用于准确分类胸腺瘤亚型的特定蛋白特征,这有助于对胸腺瘤患者进行准确诊断。

相似文献

1
Using proteomic profiling to characterize protein signatures of different thymoma subtypes.利用蛋白质组学分析方法来描述不同胸腺瘤亚型的蛋白质特征。
BMC Cancer. 2019 Aug 13;19(1):796. doi: 10.1186/s12885-019-6023-4.
2
Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.蛋白质组分析和组织芯片用于分析与 B 型胸腺瘤亚分类相关的蛋白标志物。
Chin Med J (Engl). 2012 Aug;125(16):2811-8.
3
Proteomic Signatures of Thymomas.胸腺瘤的蛋白质组学特征
PLoS One. 2016 Nov 10;11(11):e0166494. doi: 10.1371/journal.pone.0166494. eCollection 2016.
4
Exploring Potential Biomarkers of Early Thymoma based on Serum Proteomics.基于血清蛋白质组学探索胸腺瘤早期的潜在生物标志物。
Protein Pept Lett. 2024;31(1):74-83. doi: 10.2174/0109298665275655231103105924.
5
Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas.蛋白质组学分析鉴定精氨琥珀酸合成酶 1 和特殊 AT 富含序列结合蛋白 1 为 WHO 类型 A 和 B3 胸腺瘤免疫组织化学鉴别可靠的标志物。
Histopathology. 2023 Oct;83(4):607-616. doi: 10.1111/his.14972. Epub 2023 Jun 12.
6
Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.乳腺肿瘤的蛋白质组学分析使用不同分类器证实了mRNA内在分子亚型:对新鲜冷冻组织样本的大规模分析。
Breast Cancer Res. 2016 Jun 29;18(1):69. doi: 10.1186/s13058-016-0732-2.
7
Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.唾液蛋白质组学特征的鉴定和验证,用于卵巢癌的非侵入性检测。
Int J Biol Macromol. 2018 Mar;108:503-514. doi: 10.1016/j.ijbiomac.2017.12.014. Epub 2017 Dec 6.
8
[Expression and Diagnostic Value of NPTX1 in Thymoma Patients].[NPTX1在胸腺瘤患者中的表达及诊断价值]
Zhongguo Fei Ai Za Zhi. 2021 Jan 20;24(1):1-6. doi: 10.3779/j.issn.1009-3419.2021.102.03.
9
[Histologic subtyping and prognosis of thymoma: a study of 108 cases].胸腺瘤的组织学亚型与预后:108例研究
Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):445-9.
10
[Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].[1号染色体扩增与胸腺上皮肿瘤组织学类型的相关性]
Zhonghua Bing Li Xue Za Zhi. 2011 Dec;40(12):820-4.

引用本文的文献

1
Non-Mutational Key Features in the Biology of Thymomas.胸腺瘤生物学中的非突变关键特征
Cancers (Basel). 2024 Feb 26;16(5):942. doi: 10.3390/cancers16050942.
2
The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.胸腺上皮肿瘤的分子特征:全面综述。
Int J Mol Sci. 2024 Jan 26;25(3):1554. doi: 10.3390/ijms25031554.

本文引用的文献

1
The Integrated Genomic Landscape of Thymic Epithelial Tumors.胸腺癌的综合基因组景观。
Cancer Cell. 2018 Feb 12;33(2):244-258.e10. doi: 10.1016/j.ccell.2018.01.003.
2
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.《2015年世界卫生组织肺、胸膜、胸腺和心脏肿瘤分类》简介
J Thorac Oncol. 2015 Sep;10(9):1240-1242. doi: 10.1097/JTO.0000000000000663.
3
The impact of thymoma histotype on prognosis in a worldwide database.全球数据库中胸腺瘤组织学类型对预后的影响。
J Thorac Oncol. 2015 Feb;10(2):367-72. doi: 10.1097/JTO.0000000000000393.
4
Integrated genomic characterization of papillary thyroid carcinoma.甲状腺乳头状癌的综合基因组特征分析
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
5
Histologic classification of thymoma: a practical guide for routine cases.胸腺瘤的组织学分类:常规病例实用指南
J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S125-30. doi: 10.1097/JTO.0000000000000297.
6
Comprehensive molecular profiling of lung adenocarcinoma.肺腺癌的全面分子分析。
Nature. 2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9.
7
A genomics-based classification of human lung tumors.基于基因组学的人类肺肿瘤分类。
Sci Transl Med. 2013 Oct 30;5(209):209ra153. doi: 10.1126/scitranslmed.3006802.
8
Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.基于cDNA微阵列比较基因组杂交技术的胸腺瘤全基因组遗传畸变分析
BMC Genomics. 2007 Sep 3;8:305. doi: 10.1186/1471-2164-8-305.
9
Thymoma classification: current status and future trends.胸腺瘤分类:现状与未来趋势。
Am J Clin Pathol. 2006 Apr;125(4):542-54. doi: 10.1309/CAV8-RNU5-TKNA-CKNC.
10
Thymoma and thymic carcinoma: an update of the WHO Classification 2004.胸腺瘤和胸腺癌:2004年世界卫生组织分类的更新
Surg Today. 2005;35(10):805-11. doi: 10.1007/s00595-005-3047-y.